Discovery of GLP-1based drugs for the treatment of obesity
NEW YORK August 4, 2025 Noom, the leading digital healthcare company committed to chronic disease prevention and empowering people to live better longer, today announced the launch of the Noom Microdose GLP-1 Rx Program, a groundbreaking offering designed to unlock weight loss and long-term health benefits while minimizing side effects through personalized microdoses of GLP-1 medication, when clinically appropriate
However, 4-hydroxy-tamoxifen (4-OHT), the bioactive metabolite of tamoxifen, promoted the proliferation of sorted ER36 + MCF-7 cells (Figure 3A) but not ER36 ones (Supplementary information, Figure S3D)
Whether youre planning to have a family or wanting to avoid pregnancy, here youll find all you need to know about GLP-1s, pregnancy and contraception in our expert guide
The results indicate that either removing the pudendal nerves or pretreating with L-NAME may negate the increases in intracavernosal pressure that melanocortin agonists likely induced in the anesthetized murine models
Even ligament healing shows better functional outcomes by day 28 with BPC-157 treatment